In preclinical models of melanoma, loss of PTEN in tumor cells inhibits T-cell-mediated tumor killing and restricts T-cell trafficking into tumors.468 A number of immunosuppressive cytokines, including CCL12 and VEGF are elevated in melanoma patients harboring PTEN loss. The gene discussed is VEGFA; the disease is neoplasm.